GBA3 Antikörper (AA 1-150, AA 370-469)
Kurzübersicht für GBA3 Antikörper (AA 1-150, AA 370-469) (ABIN2719167)
Target
Alle GBA3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-150, AA 370-469
-
Produktmerkmale
- Homo sapiens glucosidase, beta, acid 3 (cytosolic) (GBA3), transcript variant 1
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Human recombinant protein fragment corresponding to amino acids 1-150 and AA 370-469 of human GBA3 (NP_066024) produced in HEK293T cell.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB 1:500~2000, FLOW 1:100
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- GBA3 (Glucosidase, Beta, Acid 3 (Cytosolic) (GBA3))
-
Andere Bezeichnung
- GBA3
-
Hintergrund
- GBA3, or cytosolic beta-glucosidase (EC 3.2.1.21), is a predominantly liver enzyme that efficiently hydrolyzes beta-D-glucoside and beta-D-galactoside, but not any known physiologic beta-glycoside, suggesting that it may be involved in detoxification of plant glycosides (de Graaf et al., 2001 [PubMed 11389701]). GBA3 also has significant neutral glycosylceramidase activity (EC 3.2.1.62), suggesting that it may be involved in a nonlysosomal catabolic pathway of glucosylceramide metabolism (Hayashi et al., 2007 [PubMed 17595169]).
-
Molekulargewicht
- 53.5 kDa
-
Gen-ID
- 57733
-
NCBI Accession
- NM_020973
-
HGNC
- 57733
Target
-